First Manhattan CO Royalty Pharma PLC Transaction History

First Manhattan CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $137 - $156	-5 Reduced 0.14%	3,500 $106,000
Q4 2023 Feb 13, 2024	BUY	$26.21 - $29.22 $131 - $146	5 Added 0.14%	3,505 $98,000
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $6,554 - $7,880	-200 Reduced 5.41%	3,500 $126,000
Q1 2021 May 14, 2021	BUY	$42.34 - $52.82 $8,468 - $10,564	200 Added 5.71%	3,700 $161,000
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $126,419 - $175,175	3,500 New	3,500 $175,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.